Vulvovaginal Candidiasis (VVC) Market View 2025: VVC Pipeline Holds Nine Molecules, With One Asset In The Pre-Registration Stage And Another Four In Phase II

(MENAFN- GlobeNewsWire - Nasdaq) China's high lifetime prevalence of VVC cases offers a significant market opportunity, despite the current saturation with generic drugs. The VVC pipeline shows potential with nine molecules in development. Recent clinical trials and strategic deals highlight strong future growth and innovation potential in the VVC market.

Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Vulvovaginal Candidiasis (VVC): Market View" report has been added to ResearchAndMarkets's offering.
This reports provides a data-driven overview of the current and future competitive landscape in VVC Therapeutics.
In 2024 and 2029, China is anticipated to have the highest number of lifetime diagnosed prevalent cases of VVC, representing a large portion of global cases. In 2024. Currently, the VVC market is saturated with generic drugs, and the lanosterol 14 alpha demethylase inhibitor drug class dominates the approved innovator drugs to treat VVC.
The VVC pipeline holds nine molecules, with one asset in the pre-registration stage and another four in Phase II. Over the past decade, 183 clinical trials have been conducted in VVC. The year with the most studies initiated was 2023, with 30 trials, followed by 2019, with 24 trials. During the past 18 months, five mergers and acquisitions and one strategic alliance involving companies developing VVC assets were completed globally.

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the VVC Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the global VVC Therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories that present the maximum opportunities for consolidations, investments, and strategic partnerships.

Key Topics Covered:
1 Preface
1.1 Contents
1.2 Report Scope
1.3 List of Tables and Figures
1.4 Abbreviations
2 Key Findings
3 Disease Landscape
3.1 Disease Overview
3.2 Epidemiology Overview
3.3 Treatment Overview
4 Marketed Drugs Assessment
4.1 Leading Marketed Drugs
4.2 Overview by Mechanism of Action
4.3 Overview by Molecule Type
4.4 Product Profiles and Sales Forecast
5 Pricing and Reimbursement Assessment
5.1 Annual Cost of Therapy
5.2 Time to Pricing and Reimbursement
6 Pipeline Drugs Assessment
6.1 Mid-to-late-stage Pipeline Drugs
6.2 Overview by Development Stage
6.3 Overview by Mechanism of Action
6.4 Overview by Molecule Type
6.5 Drug Specific Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA)
6.6 Therapy Area and Indication-specific PTSR and LoA
7 Clinical Trials Assessment
7.1 Historical Overview
7.2 Overview by Phase
7.3 Overview by Status
7.4 Overview by Phase for Ongoing and Planned Trials
7.5 Trials with Virtual Components
7.6 Overview of Trials by Geography
7.7 Single-Country and Multinational Trials by Region
7.8 Top 20 Sponsors with Breakdown by Phase
7.9 Top 20 Sponsors with Breakdown by Status
7.10 Overview by Endpoint Status
7.11 Overview by Race and Ethnicity
7.12 Enrollment Data
7.13 Top 20 countries for Trial Sites
7.14 Top 20 Sites Globally
7.15 Feasibility Analysis - Geographic Overview
7.16 Feasibility Analysis - Benchmark Models
8 Deals Landscape
8.1 Mergers, Acquisitions, and Strategic Alliances by Region
8.2 Recent Mergers, Acquisitions, and Strategic Alliances
9 Commercial Assessment
9.1 Key Market Players
10 Future Market Catalysts
For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN22092025004107003653ID1110094316